Abstract
Existing methods for the analysis of pesticides in breast milk involves multiple extraction steps requiring large sample and solvent volumes, which can be a major obstacle in large epidemiologic studies. Here, we developed a simple, low-volume method for extracting organophosphates, pyrethroids, carbamates, atrazine and imidacloprid from 100-200 µL of human breast milk. We tested microwave-assisted acid/base digestion and double solvent extraction with 2 or 20 mL of 2:1 (v/v) dichloromethane/hexane, with or without subsequent solid phase extraction (SPE) clean-up. Samples were analyzed by liquid chromatography tandem mass-spectrometry. Analyte recoveries and reproducibility were highest when 100-200 µL milk were extracted with 2 mL of dichloromethane/hexane without subsequent SPE steps. Analysis of 79 breast milk samples using this method revealed the presence of carbamates, organophsphates, pyrethroids and imidacloprid at detection frequencies of 79-96%, 53-90%, 1-7% and 61%, respectively. This study provides a simple, low-volume method for measuring pesticides in human breast milk.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT216198
Funding Statement
Research reported in this publication was supported by the National Institute of Environmental Health Sciences of the National Institutes of Health (NIH) under Award Number P30ES023513. Funding for MARBLES cohort study is provided by: STAR grant RD-83329201 from the US Environmental Protection Agency (EPA); and grants R24ES028533, R01ES028089, R01ES020392, R01ES025574, and P01ES011269 from the NIH. Funding for the UCD Lactation Study cohort is provided by the University of California Discovery Grant Program. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH, EPA or University of California.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All human subject protocols were approved by the University of California, Davis (UCD) Institutional Review Board (# 225645, 216198 and 887479). Written informed consent was obtained from all participants prior to collection of data or specimens.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The raw data are provided in the uploaded supplement.
Abbreviations
- CI
- confidence interval;
- CUDA
- 1-cyclohexyl ureido dodecanoic acid;
- CV
- coefficient of variation;
- EPA
- Environmental Protection Agency;
- IRB
- Institutional Review Board;
- LCMS
- liquid chromatography-mass spectrometry;
- LOD
- Limits of detection;
- LOQ;
- limits of quantification;
- MARBLES
- Markers of Autism Risk in Babies - Learning Early Signs;
- NIOSH
- National Institute for Occupational Safety and Health;
- PUHA
- 1-phenyl-ureido3-hexanoic acid;
- SPE
- solid phase extraction;
- UCD
- University of California - Davis
- UPLC-MS/MS
- ultra-high performance liquid chromatography coupled to tandem mass-spectrometry
